(Total Views: 582)
Posted On: 06/27/2019 10:05:46 AM
Post# of 94
![Avatar](https://investorshangout.com/images/ProfileImages/411968592_59827_pY--nyLE_400x400.png)
$ATOS News Article - Atossa Genetics' Preliminary Phase 2 Study Achieves Primary Endpoint: Topical Endoxifen Rapidly Reduces Breast Density https://marketwirenews.com/news-releases/atos...23746.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
My Twitter: WhyteStocks